CTSO Stock Initiation By Brean Murray Could Draw Investors

Penny Stock Investors may want to take a closer look at CytoSorbents Corp. (CTSO) after Wall Street analysts, Brean Murray, initiated coverage on them Tuesday. Using blood purification to treat life-threatening illnesses, the critical care focused therapeutic device company was issued a “buy” rating and a $0.50 price target, a possible 317% gain. Currently, CTSO stock price is 0.1199, up Continue Reading →

0